Cyanotech Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Cyanotech.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Personal Products winstgroei	25.3%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Feb 15

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Feb 09

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

Oct 05

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Sep 30

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

Feb 08

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

Jan 04

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 30

Cyanotech reports Q2 results

Nov 12

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Cyanotech onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

OTCPK:CYAN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	24	-5	0	0	N/A
3/31/2024	23	-5	-1	0	N/A
12/31/2023	22	-5	-1	0	N/A
9/30/2023	23	-4	0	1	N/A
6/30/2023	22	-4	-2	-1	N/A
3/31/2023	23	-3	-3	-2	N/A
12/31/2022	26	-2	-3	-2	N/A
9/30/2022	29	-1	-2	-1	N/A
6/30/2022	34	1	1	3	N/A
3/31/2022	36	2	1	2	N/A
12/31/2021	37	2	2	3	N/A
9/30/2021	35	2	1	2	N/A
6/30/2021	34	1	0	1	N/A
3/31/2021	32	1	2	2	N/A
12/31/2020	32	1	1	2	N/A
9/30/2020	32	1	3	3	N/A
6/30/2020	31	1	2	2	N/A
3/31/2020	32	0	1	1	N/A
12/31/2019	29	-1	-1	-1	N/A
9/30/2019	32	-1	0	0	N/A
6/30/2019	31	-2	-1	-1	N/A
3/31/2019	30	-4	-1	-1	N/A
12/31/2018	32	-3	-1	0	N/A
9/30/2018	31	-2	-2	-1	N/A
6/30/2018	32	-1	-1	0	N/A
3/31/2018	34	1	N/A	1	N/A
12/31/2017	33	2	N/A	2	N/A
9/30/2017	32	0	N/A	2	N/A
6/30/2017	34	0	N/A	1	N/A
3/31/2017	32	-1	N/A	1	N/A
12/31/2016	33	-5	N/A	1	N/A
9/30/2016	33	-5	N/A	2	N/A
6/30/2016	32	-5	N/A	1	N/A
3/31/2016	32	-4	N/A	1	N/A
12/31/2015	32	-1	N/A	2	N/A
9/30/2015	34	0	N/A	1	N/A
6/30/2015	34	0	N/A	1	N/A
3/31/2015	34	0	N/A	1	N/A
12/31/2014	32	0	N/A	3	N/A
9/30/2014	30	-1	N/A	2	N/A
6/30/2014	29	-1	N/A	2	N/A
3/31/2014	28	0	N/A	2	N/A
12/31/2013	29	3	N/A	1	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if CYAN's forecast earnings growth is above the savings rate (2.5%).

Winst versus markt: Insufficient data to determine if CYAN's earnings are forecast to grow faster than the US market

Hoge groeiwinsten: Insufficient data to determine if CYAN's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if CYAN's revenue is forecast to grow faster than the US market.

Hoge groei-inkomsten: Insufficient data to determine if CYAN's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if CYAN's Return on Equity is forecast to be high in 3 years time

Cyanotech Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Cyanotech Corporation Announces CFO Changes

Cyanotech Corporation Announces CFO Changes

Cyanotech Corporation, Annual General Meeting, Aug 22, 2024

The Nasdaq Stock Market to Delist the Common Stock of Cyanotech

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

New minor risk - Share price stability

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Cyanotech Receives Notification Letter from The Nasdaq Stock Market LLC Regarding Not Regains Compliance with the Bid Price Rule and Not Eligible for Second 180-Day Period

New major risk - Financial position

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Third quarter 2024 earnings released: US$0.16 loss per share (vs US$0.095 loss in 3Q 2023)

Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.15 loss in 2Q 2023)

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

First quarter 2024 earnings released: US$0.22 loss per share (vs US$0.076 loss in 1Q 2023)

Cyanotech Receives Notification Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement for its Common Stock

Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer

Cyanotech Corporation, Annual General Meeting, Aug 24, 2023

New minor risk - Share price stability

Full year 2023 earnings released: US$0.55 loss per share (vs US$0.35 profit in FY 2022)

Cyanotech Receives a Notification Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Bid Price Rule

Third quarter 2023 earnings released: US$0.095 loss per share (vs US$0.062 profit in 3Q 2022)

Second quarter 2023 earnings released: US$0.15 loss per share (vs US$0.16 profit in 2Q 2022)

Investor sentiment improved over the past week

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why Cyanotech (NASDAQ:CYAN) Can Manage Its Debt Responsibly

First quarter 2023 earnings released: US$0.076 loss per share (vs US$0.085 profit in 1Q 2022)

Cyanotech GAAP EPS of -$0.08, revenue of $6.72M

Cyanotech Corporation, Annual General Meeting, Aug 25, 2022

Cyanotech Corporation Announces Management Changes

Full year 2022 earnings released: EPS: US$0.35 (vs US$0.15 in FY 2021)

Cyanotech (NASDAQ:CYAN) Might Have The Makings Of A Multi-Bagger

Is Cyanotech (NASDAQ:CYAN) A Risky Investment?

Insufficient new directors

The ESG Future Of Food Protein Production: Cyanotech

Cyanotech (NASDAQ:CYAN) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Cyanotech (NASDAQ:CYAN) Can Stay On Top Of Its Debt

Independent Chairman of the Board recently bought US$126k worth of stock

Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital

Second quarter 2022 earnings released: EPS US$0.16 (vs US$0.026 in 2Q 2021)

First quarter 2022 earnings released: EPS US$0.085 (vs US$0.023 in 1Q 2021)

Full year 2021 earnings released: EPS US$0.15 (vs US$0.065 in FY 2020)

Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$4.12

Cyanotech's (NASDAQ:CYAN) Promising Earnings May Rest On Soft Foundations

Third quarter 2021 earnings released: EPS US$0.14 (vs US$0.029 in 3Q 2020)

New 90-day high: US$3.92

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

New 90-day high: US$3.40

New 90-day high: US$3.22

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

New 90-day high: US$3.17

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Independent Director recently sold US$108k worth of stock

Second quarter 2021 earnings released: EPS US$0.026

Cyanotech reports Q2 results

Market bids up stock over the past week

Market bids up stock over the past week

Cyanotech Corporation Launches Bioastin

New 90-day high - US$2.85

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven